Analysts Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Target Price at $137.92 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Rating of "Moderate Buy" by Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ingrid Delaet Sells 5,000 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
48,819 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Bought by Tudor Investment Corp Et Al theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Tudor Investment Corp Et Al Invests $5.49 Million in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.